Does tardive dyskinesia (TD) typically present with symptoms at rest, and can it be associated with a shuffling gait in an adult or elderly patient with a history of neurological or psychiatric conditions?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 30, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Tardive Dyskinesia Does NOT Typically Present at Rest and Does NOT Cause Shuffling Gait

Tardive dyskinesia (TD) is characterized by rapid, involuntary choreiform and athetoid movements—not symptoms at rest or shuffling gait, which are hallmarks of parkinsonism, not TD. 1

Clinical Presentation of TD

TD manifests as hyperkinetic involuntary movements that are present during wakefulness and typically worsen with voluntary movement or stress, not at rest 2, 3:

  • Orofacial region most commonly affected: rapid involuntary facial movements including blinking, grimacing, chewing, or tongue movements 1
  • Choreiform and athetoid movements: rhythmic, repetitive, stereotypic movements of the face, mouth, tongue, trunk, and extremities 3, 4
  • Not tremor as a primary feature: TD involves chorea and athetosis, distinctly different from resting tremor 1

Shuffling Gait is NOT a Feature of TD

A shuffling gait indicates drug-induced parkinsonism or Parkinson's disease, not tardive dyskinesia 1:

  • Shuffling gait is a cardinal motor feature of parkinsonism (bradykinesia with rigidity), which represents a separate drug-induced movement disorder 5
  • Rule out drug-induced parkinsonism when evaluating abnormal movements, as it requires different management than TD 1
  • Dopaminergic imaging may assist in differentiating drug-induced parkinsonism from neurodegenerative causes when diagnostic uncertainty exists 5

Critical Differential Diagnosis

When evaluating movement disorders in patients on dopamine receptor-blocking agents, distinguish between 1, 2:

  • Tardive dyskinesia: choreiform/athetoid hyperkinetic movements
  • Drug-induced parkinsonism: bradykinesia, rigidity, resting tremor, shuffling gait
  • Acute dystonia: sustained muscle spasms
  • Akathisia: inner restlessness with pacing

Common Pitfall to Avoid

Do not confuse TD with parkinsonism—they are phenomenologically distinct tardive syndromes that may occur simultaneously in the same patient but require different treatment approaches 2. TD involves excessive involuntary movements, while parkinsonism involves reduced movement and rigidity 1.

If TD is Confirmed

For moderate to severe TD, treat with a VMAT2 inhibitor (valbenazine or deutetrabenazine) as first-line pharmacotherapy 1, 6:

  • Gradually withdraw the offending antipsychotic if clinically feasible 1, 6
  • Never use anticholinergic medications (benztropine, trihexyphenidyl) for TD—they are contraindicated and may worsen the condition 6
  • Consider switching to clozapine if continued antipsychotic therapy is necessary, as it has the lowest risk profile for movement disorders 1, 6

If Parkinsonism is Present Instead

For drug-induced parkinsonism with shuffling gait 5:

  • Reduce antipsychotic dose if psychiatric condition allows
  • Consider switching to an atypical antipsychotic with lower D2 affinity
  • Dopaminergic imaging may help differentiate from early-onset Parkinson's disease, which has increased prevalence in certain populations 5

References

Guideline

Management of Tardive Dyskinesia

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Research

Tardive Dystonia.

Current treatment options in neurology, 2005

Research

Tardive dyskinesia.

The Western journal of medicine, 1990

Research

Pathophysiology, prognosis and treatment of tardive dyskinesia.

Therapeutic advances in psychopharmacology, 2022

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Treatment of Persistent Tardive Dyskinesia

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.